Literature DB >> 12054596

Genetic analysis of four novel peroxisome proliferator activated receptor-gamma splice variants in monkey macrophages.

Jiming Zhou1, Katina M Wilson, Jheem D Medh.   

Abstract

Peroxisome proliferator activated receptor-gamma (PPAR-gamma) is abundantly expressed in atherosclerotic lesions and is implicated in atherogenesis. The existence of three splice variants, PPAR-gamma 1, PPAR-gamma 2, and PPAR-gamma 3 has been established. Using monocyte-derived macrophages from cynomolgus monkeys, we demonstrate here the identification of two new PPAR-gamma exons, exon C and exon D, which splice together with already established exons A1, A2, and B in the 5(') terminal region to generate four novel PPAR-gamma subtypes, PPAR-gamma 4, -gamma 5, -gamma 6, and -gamma 7. PPAR-gamma 4 and gamma 5 were detected only in macrophages whereas gamma 6 and gamma 7 were expressed both in macrophages and adipose tissues. None of these novel isoforms were detected in muscle, kidney, and spleen from monkeys. We found sequences identical to exons C and D in the human genome database. These and all PPAR-gamma exons known to date are encoded by a single gene, located from region 10498 K to 10384 K on human chromosome 3. We cloned and expressed PPAR-gamma 1, PPAR-gamma 4, and PPAR-gamma 5 proteins in yeast using the expression vector pPICZB. As expected, all recombinant proteins showed a molecular weight of approximately 50 kDa. We also investigated the effect of a high-fat diet on the level of macrophage PPAR-gamma expression in monkeys. RT-PCR showed a significant increase in total PPAR-gamma and ABCA1 mRNA levels in macrophages of fat-fed monkeys (n=7) compared to those maintained on a normal diet (n=2). However, none of the novel isoforms seemed to be induced by fat-feeding. We used tetracycline-responsive expression vectors to obtain moderate expression of PPAR-gamma 4 and -gamma 5 in CHO cells. In these cells, expression of PPAR-gamma 5 but not -gamma 4 repressed the expression of ABCA1. Neither isoform modulated the expression of lipoprotein lipase. Our results suggest that individual PPAR-gamma isoforms may be responsible for unique tissue-specific biological effects and that PPAR-gamma 4 and -gamma 5 may modulate macrophage function and atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054596      PMCID: PMC2775714          DOI: 10.1016/S0006-291X(02)00138-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

Review 1.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

Review 2.  Nuclear-receptor ligands and ligand-binding domains.

Authors:  R V Weatherman; R J Fletterick; T S Scanlan
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache.

Authors:  E D Rosen; B M Spiegelman
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.

Authors:  A Meirhaeghe; L Fajas; N Helbecque; D Cottel; J Auwerx; S S Deeb; P Amouyel
Journal:  Int J Obes Relat Metab Disord       Date:  2000-02

5.  Insulin resistance and human disease: a short history.

Authors:  G M Reaven
Journal:  J Basic Clin Physiol Pharmacol       Date:  1998

Review 6.  Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.

Authors:  S Rocchi; J Auwerx
Journal:  Ann Med       Date:  1999-10       Impact factor: 4.709

7.  PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

Authors:  G Chinetti; S Lestavel; V Bocher; A T Remaley; B Neve; I P Torra; E Teissier; A Minnich; M Jaye; N Duverger; H B Brewer; J C Fruchart; V Clavey; B Staels
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

8.  Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.

Authors:  A C Li; K K Brown; M J Silvestre; T M Willson; W Palinski; C K Glass
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

9.  Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity.

Authors:  D Evans; W A Mann; J de Heer; U Michel; D Wendt; B Kortner; A Wolf; U Beisiegel
Journal:  Int J Obes Relat Metab Disord       Date:  2000-05

10.  Analysis of the peroxisome proliferator activated receptor gamma (PPARgamma) gene in HAIRAN syndrome with obesity.

Authors:  H Globerman; Y Zauberman; T Makarov; B A Beamer; C J Yen; A R Shuldiner; C Harel; E Karnieli
Journal:  Clin Endocrinol (Oxf)       Date:  2000-04       Impact factor: 3.478

View more
  18 in total

Review 1.  Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders.

Authors:  Yu-Chang Chen; Jui-Sheng Wu; Hsin-Da Tsai; Chien-Yu Huang; Jin-Jer Chen; Grace Y Sun; Teng-Nan Lin
Journal:  Mol Neurobiol       Date:  2012-03-21       Impact factor: 5.590

Review 2.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

3.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

4.  PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.

Authors:  Valerio Costa; Maria Assunta Gallo; Francesca Letizia; Marianna Aprile; Amelia Casamassimi; Alfredo Ciccodicola
Journal:  PPAR Res       Date:  2010-09-08       Impact factor: 4.964

5.  Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ.

Authors:  Un Ju Jung; Claudia Torrejon; Chuchun L Chang; Hiroko Hamai; Tilla S Worgall; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-04       Impact factor: 8.311

6.  Identification and regulation of novel PPAR-gamma splice variants in human THP-1 macrophages.

Authors:  Ye Chen; Anna R Jimenez; Jheem D Medh
Journal:  Biochim Biophys Acta       Date:  2006-02-13

Review 7.  Thiazolidinediones: effects on insulin resistance and the cardiovascular system.

Authors:  C E Quinn; P K Hamilton; C J Lockhart; G E McVeigh
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

8.  Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates.

Authors:  Christine Swanson; Marina Emborg
Journal:  Neurol Res       Date:  2013-12-27       Impact factor: 2.448

Review 9.  Peroxisome proliferator-activated receptors for hypertension.

Authors:  Daisuke Usuda; Tsugiyasu Kanda
Journal:  World J Cardiol       Date:  2014-08-26

10.  Regulation of Translational Efficiency by Disparate 5' UTRs of PPARgamma Splice Variants.

Authors:  Shawn McClelland; Roopali Shrivastava; Jheem D Medh
Journal:  PPAR Res       Date:  2009-11-23       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.